Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
33.3M
-
Shares change
-
+1.91M
-
Total reported value, excl. options
-
$969M
-
Value change
-
+$55.8M
-
Number of buys
-
24
-
Number of sells
-
-28
-
Price
-
$29.27
Significant Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q1 2021
75 filings reported holding KRON - Kronos Bio, Inc. - Common Stock as of Q1 2021.
Kronos Bio, Inc. - Common Stock (KRON) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.3M shares
.
Largest 10 shareholders include Omega Fund Management, LLC (3.82M shares), Capital Research Global Investors (3.54M shares), PERCEPTIVE ADVISORS LLC (2.78M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.11M shares), Capital World Investors (1.99M shares), FMR LLC (1.97M shares), BlackRock Inc. (1.64M shares), JPMORGAN CHASE & CO (1.62M shares), VANGUARD GROUP INC (1.46M shares), and Wildcat Capital Management, LLC (1.44M shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.